| Unique ID issued by UMIN | UMIN000055148 |
|---|---|
| Receipt number | R000063006 |
| Scientific Title | Effects of a 12-week functional water intake on anti-fatigue and health benefits |
| Date of disclosure of the study information | 2024/08/05 |
| Last modified on | 2025/11/07 15:32:33 |
Effects of a 12-week functional water intake
Effects of a 12-week functional water intake
Effects of a 12-week functional water intake on anti-fatigue and health benefits
Effects of a 12-week functional water intake on anti-fatigue and health benefits
| Japan |
Healthy person
| Adult |
Others
NO
To assess the effects of a 12-week functional water intake on anti-fatigue and health benefits.
Efficacy
Confirmatory
Explanatory
Not applicable
Comparison of psychological, physiological, and biochemical parameters before and after the intake of the functional water.
Interventional
Parallel
Randomized
Individual
Single blind -investigator(s) and assessor(s) are blinded
Placebo
2
Prevention
| Food |
Intake of the test drink twice a day for 12 weeks
Intake of the placebo drink twice a day for 12 weeks
| 20 | years-old | <= |
| 65 | years-old | >= |
Male and Female
1. Individuals aged 20 to 65 years who do not meet the exclusion criteria.
2. Individuals who understand the contents of the informed consent explanation and can provide written consent voluntarily.
1. Individuals with a history of serious diseases related to the brain, nervous system, cardiovascular system, or other severe conditions, or those currently undergoing treatment, including those taking prescribed medication.
2. Individuals with a history of seizures (such as loss of consciousness, coma, convulsions, etc.).
3. Individuals currently suffering from peptic ulcers (such as gastric ulcers).
4. Individuals with hearing or vision impairments that make it difficult to complete the essential evaluation items of this study.
5. Individuals who are currently pregnant or breastfeeding.
6. Individuals who cannot consume sugar-free carbonated beverages and cold drinks.
7. Individuals who have experienced symptoms of a vasovagal response due to blood sampling in the past.
8. Individuals currently participating in another clinical trial or who have participated in another interventional clinical trial within one month prior to obtaining consent.
9. Individuals who cannot comply with operational instructions for the trial (e.g., wearing masks for infection prevention).
10. Individuals deemed unsuitable by the principal investigator.
80
| 1st name | Kei |
| Middle name | |
| Last name | Mizuno |
Osaka Metropolitan University
Center for Health Science Innovation
5300011
3-1 Ofuka-cho, Kita-ku, Osaka City, JAPAN
+81-6-6485-0288
kyosuke.watanabe@dragon.kobe-u.ac.jp
| 1st name | Kyosuke |
| Middle name | |
| Last name | Watanabe |
Osaka Metropolitan University
Center for Health Science Innovation
5300011
3-1 Ofuka-cho, Kita-ku, Osaka City, JAPAN
+81-6-6485-0288
kyosuke.watanabe@dragon.kobe-u.ac.jp
ASAHI SOFT DRINKS CO., LTD.
ASAHI SOFT DRINKS CO., LTD.
Profit organization
Ethics Committee of Precision Healthcare Research Organization
1-8-30 Tenmabashi, Kita-ku, Osaka City
+81-6-4309-6075
info@j-phr.org
NO
| 2024 | Year | 08 | Month | 05 | Day |
Unpublished
No longer recruiting
| 2024 | Year | 06 | Month | 29 | Day |
| 2024 | Year | 07 | Month | 12 | Day |
| 2024 | Year | 09 | Month | 07 | Day |
| 2024 | Year | 12 | Month | 08 | Day |
| 2024 | Year | 08 | Month | 02 | Day |
| 2025 | Year | 11 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063006